# WEX Inc.: financial statements, quarterly

WEX · NYSE · CIK 1309108 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wex.md) · [Financials](/companies/wex/financials.md) · [Filings](/companies/wex/filings.md) · [Insiders](/companies/wex/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wex/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [469](/filings/0001309108-24-000201.md) | [481 d](/filings/0001309108-26-000010.md) | [469](/filings/0001309108-25-000087.md) | [479](/filings/0001309108-25-000174.md) | [479](/filings/0001309108-25-000190.md) | [440 d](/filings/0001309108-26-000010.md) | [444](/filings/0001309108-26-000017.md) | [454](/filings/0001309108-26-000029.md) | [482](/filings/0001309108-25-000190.md) | [465 d](/filings/0001309108-26-000010.md) | [462](/filings/0001309108-26-000017.md) | [513](/filings/0001309108-26-000029.md) |
| Cost of revenue | $m | [235](/filings/0001309108-24-000201.md) | [256 d](/filings/0001309108-26-000010.md) | [267](/filings/0001309108-25-000087.md) | [264](/filings/0001309108-25-000174.md) | [249](/filings/0001309108-25-000190.md) | [258 d](/filings/0001309108-26-000010.md) | [270](/filings/0001309108-26-000017.md) | [273](/filings/0001309108-26-000029.md) | [274](/filings/0001309108-25-000190.md) | [284 d](/filings/0001309108-26-000010.md) | [280](/filings/0001309108-26-000017.md) | [290](/filings/0001309108-26-000029.md) |
| Operating income | $m | [175](/filings/0001309108-24-000201.md) | [159 d](/filings/0001309108-26-000010.md) | [165](/filings/0001309108-25-000087.md) | [168](/filings/0001309108-25-000174.md) | [196](/filings/0001309108-25-000190.md) | [157 d](/filings/0001309108-26-000010.md) | [157](/filings/0001309108-26-000017.md) | [157](/filings/0001309108-26-000029.md) | [184](/filings/0001309108-25-000190.md) | [166 d](/filings/0001309108-26-000010.md) | [158](/filings/0001309108-26-000017.md) | [203](/filings/0001309108-26-000029.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [26.0](/filings/0001309108-24-000201.md) | [23.5 d](/filings/0001309108-26-000010.md) | [24.2](/filings/0001309108-25-000087.md) | [29.1](/filings/0001309108-25-000174.md) | [38.2](/filings/0001309108-25-000190.md) | [16.6 d](/filings/0001309108-26-000010.md) | [28.9](/filings/0001309108-26-000017.md) | [25.2](/filings/0001309108-26-000029.md) | [36.2](/filings/0001309108-25-000190.md) | [25.8 d](/filings/0001309108-26-000010.md) | [30.8](/filings/0001309108-26-000017.md) | [41.9](/filings/0001309108-26-000029.md) |
| Net income | $m | [18.4](/filings/0001309108-24-000201.md) | [84.9 d](/filings/0001309108-26-000010.md) | [65.8](/filings/0001309108-25-000190.md) | [77.0](/filings/0001309108-25-000190.md) | [103](/filings/0001309108-25-000190.md) | [63.9 d](/filings/0001309108-26-000010.md) | [71.5](/filings/0001309108-26-000029.md) | [68.1](/filings/0001309108-26-000029.md) | [80.3](/filings/0001309108-25-000190.md) | [84.3 d](/filings/0001309108-26-000010.md) | [77.7](/filings/0001309108-26-000029.md) | [109](/filings/0001309108-26-000029.md) |
| Diluted EPS | $ per share | [0.42](/filings/0001309108-24-000201.md) | not reported | [1.55](/filings/0001309108-25-000087.md) | [1.83](/filings/0001309108-25-000174.md) | [2.52](/filings/0001309108-25-000190.md) | not reported | [1.81](/filings/0001309108-26-000017.md) | [1.98](/filings/0001309108-26-000029.md) | [2.30](/filings/0001309108-25-000190.md) | not reported | [2.22](/filings/0001309108-26-000017.md) | [3.11](/filings/0001309108-26-000029.md) |
| Basic EPS | $ per share | [0.43](/filings/0001309108-24-000201.md) | not reported | [1.57](/filings/0001309108-25-000087.md) | [1.85](/filings/0001309108-25-000174.md) | [2.56](/filings/0001309108-25-000190.md) | not reported | [1.84](/filings/0001309108-26-000017.md) | [1.98](/filings/0001309108-26-000029.md) | [2.34](/filings/0001309108-25-000190.md) | not reported | [2.25](/filings/0001309108-26-000017.md) | [3.13](/filings/0001309108-26-000029.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.0](/filings/0001309108-24-000201.md) | [1.0](/filings/0001309108-25-000017.md) | [0.8](/filings/0001309108-25-000087.md) | [0.7](/filings/0001309108-24-000175.md) | [0.5](/filings/0001309108-24-000201.md) | [0.6](/filings/0001309108-26-000010.md) | [0.6](/filings/0001309108-26-000017.md) | [0.8](/filings/0001309108-26-000029.md) | [0.8](/filings/0001309108-25-000190.md) | [0.9](/filings/0001309108-26-000029.md) | [0.6](/filings/0001309108-26-000017.md) | [1.2](/filings/0001309108-26-000029.md) |
| Current assets | $bn | [9.1](/filings/0001309108-23-000183.md) | [8.9](/filings/0001309108-25-000017.md) | [9.5](/filings/0001309108-24-000116.md) | [9.4](/filings/0001309108-24-000175.md) | [9.1](/filings/0001309108-24-000201.md) | [8.5](/filings/0001309108-26-000010.md) | [9.2](/filings/0001309108-25-000087.md) | [9.9](/filings/0001309108-25-000174.md) | [9.7](/filings/0001309108-25-000190.md) | [9.7](/filings/0001309108-26-000029.md) | [10.7](/filings/0001309108-26-000017.md) | [11.8](/filings/0001309108-26-000029.md) |
| Total assets | $bn | [13.9](/filings/0001309108-23-000183.md) | [13.9](/filings/0001309108-25-000017.md) | [14.4](/filings/0001309108-24-000116.md) | [14.2](/filings/0001309108-24-000175.md) | [14.0](/filings/0001309108-24-000201.md) | [13.3](/filings/0001309108-26-000010.md) | [14.0](/filings/0001309108-25-000087.md) | [14.7](/filings/0001309108-25-000174.md) | [14.4](/filings/0001309108-25-000190.md) | [14.4](/filings/0001309108-26-000029.md) | [15.4](/filings/0001309108-26-000017.md) | [16.5](/filings/0001309108-26-000029.md) |
| Current liabilities | $bn | [8.9](/filings/0001309108-23-000183.md) | [8.5](/filings/0001309108-25-000017.md) | [9.0](/filings/0001309108-24-000116.md) | [9.1](/filings/0001309108-24-000175.md) | [8.7](/filings/0001309108-24-000201.md) | [8.3](/filings/0001309108-26-000010.md) | [8.8](/filings/0001309108-25-000087.md) | [9.5](/filings/0001309108-25-000174.md) | [9.3](/filings/0001309108-25-000190.md) | [9.3](/filings/0001309108-26-000029.md) | [10.2](/filings/0001309108-26-000017.md) | [11.3](/filings/0001309108-26-000029.md) |
| Total liabilities | $bn | [12.2](/filings/0001309108-23-000183.md) | [12.1](/filings/0001309108-25-000017.md) | [12.6](/filings/0001309108-24-000116.md) | [12.5](/filings/0001309108-24-000175.md) | [12.3](/filings/0001309108-24-000201.md) | [11.8](/filings/0001309108-26-000010.md) | [13.2](/filings/0001309108-25-000087.md) | [13.7](/filings/0001309108-25-000174.md) | [13.3](/filings/0001309108-25-000190.md) | [13.2](/filings/0001309108-26-000029.md) | [14.2](/filings/0001309108-26-000017.md) | [15.2](/filings/0001309108-26-000029.md) |
| Long-term debt | $bn | [2.7](/filings/0001309108-23-000183.md) | [2.8](/filings/0001309108-25-000017.md) | [3.1](/filings/0001309108-24-000116.md) | [3.0](/filings/0001309108-24-000175.md) | [3.1](/filings/0001309108-24-000201.md) | [3.1](/filings/0001309108-26-000010.md) | [4.1](/filings/0001309108-25-000087.md) | [3.9](/filings/0001309108-25-000174.md) | [3.7](/filings/0001309108-25-000190.md) | [3.5](/filings/0001309108-26-000029.md) | [3.6](/filings/0001309108-26-000017.md) | [3.5](/filings/0001309108-26-000029.md) |
| Current portion of debt | $bn | [0.1](/filings/0001309108-23-000183.md) | [0.1](/filings/0001309108-25-000017.md) | [0.1](/filings/0001309108-24-000116.md) | [0.1](/filings/0001309108-24-000175.md) | [0.1](/filings/0001309108-24-000201.md) | [0.1](/filings/0001309108-26-000010.md) | [0.1](/filings/0001309108-25-000087.md) | [0.1](/filings/0001309108-25-000174.md) | [0.1](/filings/0001309108-25-000190.md) | [0.1](/filings/0001309108-26-000029.md) | [0.1](/filings/0001309108-26-000017.md) | [0.1](/filings/0001309108-26-000029.md) |
| Short-term borrowings | $bn | [1.0](/filings/0001309108-23-000183.md) | [1.0](/filings/0001309108-25-000017.md) | [1.1](/filings/0001309108-24-000116.md) | [1.2](/filings/0001309108-24-000175.md) | [1.4](/filings/0001309108-24-000201.md) | [1.3](/filings/0001309108-26-000010.md) | [1.5](/filings/0001309108-25-000087.md) | [1.5](/filings/0001309108-25-000174.md) | [1.3](/filings/0001309108-25-000190.md) | [1.3](/filings/0001309108-26-000029.md) | [1.6](/filings/0001309108-26-000017.md) | [1.8](/filings/0001309108-26-000029.md) |
| Shareholders' equity | $bn | [1.7](/filings/0001309108-24-000201.md) | [1.8](/filings/0001309108-26-000010.md) | [1.8](/filings/0001309108-25-000190.md) | [1.8](/filings/0001309108-25-000190.md) | [1.7](/filings/0001309108-25-000190.md) | [1.5](/filings/0001309108-26-000029.md) | [0.8](/filings/0001309108-26-000029.md) | [1.0](/filings/0001309108-26-000029.md) | [1.1](/filings/0001309108-25-000190.md) | [1.2](/filings/0001309108-26-000029.md) | [1.3](/filings/0001309108-26-000029.md) | [1.3](/filings/0001309108-26-000029.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [46.5 d](/filings/0001309108-24-000201.md) | [762 d](/filings/0001309108-26-000010.md) | [(153)](/filings/0001309108-25-000087.md) | [(7.0) d](/filings/0001309108-25-000174.md) | [3.3 d](/filings/0001309108-25-000190.md) | [638 d](/filings/0001309108-26-000010.md) | [(482)](/filings/0001309108-26-000017.md) | [265 d](/filings/0001309108-26-000029.md) | [377 d](/filings/0001309108-25-000190.md) | [295 d](/filings/0001309108-26-000010.md) | [(331)](/filings/0001309108-26-000017.md) | [(77.6) d](/filings/0001309108-26-000029.md) |
| Capital expenditure | $m | [36.4 d](/filings/0001309108-24-000201.md) | [41.9 d](/filings/0001309108-26-000010.md) | [34.0](/filings/0001309108-25-000087.md) | [39.6 d](/filings/0001309108-25-000174.md) | [35.0 d](/filings/0001309108-25-000190.md) | [38.7 d](/filings/0001309108-26-000010.md) | [32.6](/filings/0001309108-26-000017.md) | [34.6 d](/filings/0001309108-26-000029.md) | [35.0 d](/filings/0001309108-25-000190.md) | [58.6](/filings/0001309108-26-000010.md) | [37.5](/filings/0001309108-26-000017.md) | [43.5 d](/filings/0001309108-26-000029.md) |
| Share repurchases | $m | [48.6 d](/filings/0001309108-24-000201.md) | [151 d](/filings/0001309108-26-000010.md) | [73.6](/filings/0001309108-25-000087.md) | [100 d](/filings/0001309108-25-000174.md) | [370 d](/filings/0001309108-25-000190.md) | [108 d](/filings/0001309108-26-000010.md) | [790](/filings/0001309108-26-000017.md) | [9.7 d](/filings/0001309108-26-000029.md) | [0.1 d](/filings/0001309108-25-000190.md) | [0.0 d](/filings/0001309108-26-000010.md) | [0.0](/filings/0001309108-26-000017.md) | [63.8 d](/filings/0001309108-26-000029.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [44.2](/filings/0001309108-23-000183.md) | [43.6](/filings/0001309108-24-000116.md) | [43.4](/filings/0001309108-24-000175.md) | [43.4](/filings/0001309108-24-000201.md) | [42.4](/filings/0001309108-25-000087.md) | [42.0](/filings/0001309108-25-000174.md) | [40.8](/filings/0001309108-25-000190.md) | [39.4](/filings/0001309108-26-000017.md) | [34.4](/filings/0001309108-26-000029.md) | [34.8](/filings/0001309108-25-000190.md) | [35.0](/filings/0001309108-26-000017.md) | [34.9](/filings/0001309108-26-000029.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 34,081,611 at 2026-07-17, from the cover of the [10-Q filed 2026-07-23](/filings/0001309108-26-000029.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.